help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petruzziello, A.
Right arrow Articles by Beguinot, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petruzziello, A.
Right arrow Articles by Beguinot, F.

Journal of Clinical Endocrinology & Metabolism, Vol 77, 409-412, Copyright © 1993 by Endocrine Society

ARTICLES

Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation

A Petruzziello, P Formisano, C Miele, B Di Finizio, G Riccardi, A Ferrara, L Beguinot and F Beguinot
Centro di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.

Insulin action was investigated in cultured skin fibroblasts from two consanguineous patients with a heterozygous point mutation in the insulin receptor kinase (Arg1152-Gln). In spite of normal binding, Gln1152 insulin receptor exhibited 20% increased basal kinase activity, but significantly reduced insulin-dependent autophosphorylation and kinase activity compared to controls from either weight-matched noninsulin-dependent diabetic patients (n = 4) or normal subjects (n = 5). In fibroblasts from the mutant patients, basal alpha- aminoisobutyric acid and 2-deoxyglucose (2-DG) uptake, cytochalasin-B (CB) plasma membrane binding, and glycogen synthase activity were increased to levels similar to those in maximally insulin-stimulated control cells. No insulin stimulation of these metabolic effects was detected in the mutant cells. In spite of the high basal 2-DG uptake and CB binding and the lack of further insulin response, fibroblasts from the mutant patients responded to 12-O-tetradecanoylphorbol-13- acetate with a further 50% increase in 2-DG uptake and CB binding. The magnitude of the effects of insulin and 12-O-tetradecanoylphorbol-13- acetate in control cells were nearly identical. We conclude that the Gln1152 insulin receptor impairs insulin regulation of metabolic responses in patient cells. Its presence in fibroblasts from the mutant patients appears to be accompanied by an increased pool of glucose transporters.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. Caruso, C. Miele, P. Formisano, G. Condorelli, G. Bifulco, A. Oliva, R. Auricchio, G. Riccardi, B. Capaldo, and F. Beguinot
In Skeletal Muscle, Glucose Storage and Oxidation Are Differentially Impaired by the IR1152 Mutant Receptor
J. Biol. Chem., March 14, 1997; 272(11): 7290 - 7297.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Miele, P. Formisano, K.-J. Sohn, M. Caruso, M. Pianese, G. Palumbo, L. Beguinot, and F. Beguinot
Decreased Phosphorylation of Mutant Insulin Receptor by Protein Kinase C and Protein Kinase A
J. Biol. Chem., June 30, 1995; 270(26): 15844 - 15852.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society